caa a22 4500 46902643X CHVBK 20180323132731.0 cr unu---uuuuu 170328e19920801xx s 000 0 eng 10.1007/BF01962543 doi (NATIONALLICENCE)springer-10.1007/BF01962543 Van der Kuy A. Hospital Pharmacy Midden-Brabant, P.O. Box 90107, 5000, LA Tilburg, the Netherlands aut Future developments in the pharmacotherapy of lung disease [Elektronische Daten] [A. Van der Kuy] Future advances in the pharmacotherapy of lung disease will occur mainly in the treatment of asthma, and will include the development of new long-actingβ 2-agonists, long-acting parasympatholytics, phosphodiesterase inhibitors, corticosteroids with fewer systemic side-effects, and other antiinflammatory drugs. Free radicals play an important role in most lung diseases, including asthma, emphysema, fibrosis, and adult respiratory distress syndrome. The search for free radical scavengers is now in progress. Replacement therapy with α1-antitrypsin and surfactant is now possible. Progress in this area stems principally from a better understanding of the pathogenesis of lung disease. Royal Dutch Association for Advancement of Pharmacy, 1992 β 2-Agonists, long-acting nationallicence α 1-Antitrypsin, deficiency nationallicence Corticosteroids nationallicence Free radical scavengers nationallicence Parasympatholytics, long-acting nationallicence Phosphodiesterase inhibitors nationallicence Surfactant nationallicence Pharmaceutisch Weekblad Kluwer Academic Publishers 14/4(1992-08-01), 221-223 0031-6911 14:4<221 1992 14 11096 https://doi.org/10.1007/BF01962543 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/BF01962543 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Van der Kuy A. Hospital Pharmacy Midden-Brabant, P.O. Box 90107, 5000, LA Tilburg, the Netherlands aut NATIONALLICENCE 773 0- Pharmaceutisch Weekblad Kluwer Academic Publishers 14/4(1992-08-01), 221-223 0031-6911 14:4<221 1992 14 11096 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer